Apollomics, Inc.

NASDAQ:APLM

Biotechnology

Healthcare
$17.84 +34.72%

+$6.03 today

Market cap
$52.00M
Beta
1.45
P/E (TTM)
-3.1
EPS (TTM)
-$25.98
52W Low $3.66High $42.12

Volume 0.02M

Average 0.02M

Income Statement

Follow revenue through to earnings.

Revenue

$8.50M

FY 2025 · Annual

+4192.9% YoY

Operating Income

-$9.47M

FY 2025 · Annual

Net Income

-$10.94M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2K323K821K198K8.5M
Cost of Revenue0000255K
Gross Profit2K323K821K198K8.25M
Gross Margin100.0%100.0%100.0%100.0%97.0%
Research & Development35.57M35.46M34.19M24.57M5.53M
Selling, General & Admin15.29M9.95M20.64M17.77M12.44M
Operating Expenses50.86M45.4M54.83M42.33M17.72M
Depreciation & Amortization153K182K103K72K255K
EBITDA(50.12M)(43.88M)(53.45M)(41.06M)(9.22M)
EBITDA Margin-2505850.0%-13586.1%-6509.9%-20734.8%-108.4%
Operating Income(50.86M)(45.08M)(54.01M)(42.14M)(9.47M)
Operating Margin-2542850.0%-13957.0%-6578.9%-21280.8%-111.4%
Interest Income467K431K753K480K152K
Interest Expense83K93K150K179K65K
Other Income / Expenses(43.94M)(195.73M)(118.58M)(11.46M)(1.46M)
Income Before Tax(94.8M)(240.81M)(172.59M)(53.6M)(10.94M)
Pre-Tax Margin-4739800.0%-74554.2%-21022.0%-27070.2%-128.7%
Income Tax Expense1K1K10K259K3K
Net Income(94.8M)(240.81M)(172.6M)(53.86M)(10.94M)
Net Margin-4739850.0%-74554.5%-21023.3%-27201.0%-128.7%
EPS (Basic)(23.45)(61.60)(231.99)(52.80)(7.57)
EPS (Diluted)(23.45)(61.60)(231.99)(52.80)(7.57)
Weighted Avg Shares867.96K867.96K743.97K926.47K1.45M
Weighted Avg Shares (Diluted)867.96K867.96K743.97K926.47K1.45M

APLM Earnings Waterfall · TTM

NASDAQ:APLM · Revenue to Net Income

Key Ratios

EPS$-62.49
Gross Margin75.0%
Net Margin-237.7%
P/E Ratio0.2
P/S Ratio1.3

Analysis

$8.7M of revenue converted into -$64.8M of net income for the selected period. Gross margin is 75.0% and net margin is -237.7%, showing how much revenue survives after costs and taxes. EPS is $-62.49, tying the income statement back to per-share earnings.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 6, 2026
4/A4/A filingSep 24, 2026
4/A4/A filingSep 24, 2026
4/A4/A filingSep 24, 2026
4Statement of changes in beneficial ownershipSep 17, 2026

How much revenue does APLM generate?

Apollomics, Inc. (APLM) reported $8.50M of revenue in fiscal 2025.

Is APLM profitable?

Apollomics, Inc. (APLM) reported -$10.94M of net income, with a net margin of -128.7%.